{"id":446519,"title":"Notice: Multiple Additions to the Prescription Drug List (PDL) [2023-03-08] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T12:09:12.361000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/mutliple-additions-2023-03-08.html?wbdisable=false","snippet":"Notice: Multiple Additions to the Prescription Drug List (PDL) [2023-03-08] March 8, 2023 Our file number: 23-101719-215 The purpose of this Notice of Amendment is to notify about the addition of cangrelor, ciltacabtagene autoleucel, deucravacitinib, pegcetacoplan and tirzepatide…","rawSnapshotUrl":"/api/snapshots/raw/446519","browseUrl":"https://replay.healtharchive.ca/job-6/20260103120912/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/mutliple-additions-2023-03-08.html?wbdisable=false#ha_snapshot=446519","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}